Leo Pharma and Portal Instruments this week announced a global collaboration and license agreement to develop a needle-free drug delivery system.
Through the agreement, Leo Pharma’s investigational and approved medicines will be used in combination with Portal’s needle-free drug delivery system.
Portal’s needle-free jet injector platform allows patients to self-administer biologics without needles.
Get the full story on our sister site, Drug Delivery Business News.